Page last updated: 2024-08-25

bendamustine hydrochloride and Orphan Diseases

bendamustine hydrochloride has been researched along with Orphan Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, Z; Mandernach, MW; Markham, M1

Other Studies

1 other study(ies) available for bendamustine hydrochloride and Orphan Diseases

ArticleYear
Marginal zone lymphoma-associated antiphospholipid antibodies successfully treated with bendamustine rituximab.
    BMJ case reports, 2019, Mar-14, Volume: 12, Issue:3

    Topics: Antibodies, Antiphospholipid; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Immunological; Antiphospholipid Syndrome; Bendamustine Hydrochloride; Diagnosis, Differential; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Rare Diseases; Rituximab; Treatment Outcome

2019